Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
Androgenetic alopecia (AGA) is a highly heritable condition and the most common form of hair loss in humans. Susceptibility loci have been described on the X chromosome and chromosome 20, but these loci explain a minority of its heritable variance. We conducted a large-scale meta-analysis of seven genome-wide association studies for early-onset AGA in 12,806 individuals of European ancestry. While replicating the two AGA loci on the X chromosome and chromosome 20, six novel susceptibility loci reached genome-wide significance (p = 2.62×10−9–1.01×10−12). Unexpectedly, we identified a risk allele at 17q21.31 that was recently associated with Parkinson's disease (PD) at a genome-wide significant level. We then tested the association between early-onset AGA and the risk of PD in a cross-sectional analysis of 568 PD cases and 7,664 controls. Early-onset AGA cases had significantly increased odds of subsequent PD (OR = 1.28, 95% confidence interval: 1.06–1.55, p = 8.9×10−3). Further, the AGA susceptibility alleles at the 17q21.31 locus are on the H1 haplotype, which is under negative selection in Europeans and has been linked to decreased fertility. Combining the risk alleles of six novel and two established susceptibility loci, we created a genotype risk score and tested its association with AGA in an additional sample. Individuals in the highest risk quartile of a genotype score had an approximately six-fold increased risk of early-onset AGA [odds ratio (OR) = 5.78, p = 1.4×10−88]. Our results highlight unexpected associations between early-onset AGA, Parkinson's disease, and decreased fertility, providing important insights into the pathophysiology of these conditions.
Vyšlo v časopise:
Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases. PLoS Genet 8(5): e32767. doi:10.1371/journal.pgen.1002746
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002746
Souhrn
Androgenetic alopecia (AGA) is a highly heritable condition and the most common form of hair loss in humans. Susceptibility loci have been described on the X chromosome and chromosome 20, but these loci explain a minority of its heritable variance. We conducted a large-scale meta-analysis of seven genome-wide association studies for early-onset AGA in 12,806 individuals of European ancestry. While replicating the two AGA loci on the X chromosome and chromosome 20, six novel susceptibility loci reached genome-wide significance (p = 2.62×10−9–1.01×10−12). Unexpectedly, we identified a risk allele at 17q21.31 that was recently associated with Parkinson's disease (PD) at a genome-wide significant level. We then tested the association between early-onset AGA and the risk of PD in a cross-sectional analysis of 568 PD cases and 7,664 controls. Early-onset AGA cases had significantly increased odds of subsequent PD (OR = 1.28, 95% confidence interval: 1.06–1.55, p = 8.9×10−3). Further, the AGA susceptibility alleles at the 17q21.31 locus are on the H1 haplotype, which is under negative selection in Europeans and has been linked to decreased fertility. Combining the risk alleles of six novel and two established susceptibility loci, we created a genotype risk score and tested its association with AGA in an additional sample. Individuals in the highest risk quartile of a genotype score had an approximately six-fold increased risk of early-onset AGA [odds ratio (OR) = 5.78, p = 1.4×10−88]. Our results highlight unexpected associations between early-onset AGA, Parkinson's disease, and decreased fertility, providing important insights into the pathophysiology of these conditions.
Zdroje
1. KleinRJZeissCChewEYTsaiJYSacklerRS 2005 Complement factor H polymorphism in age-related macular degeneration. Science 308 385 389
2. DonosoLAVrabecTKuivaniemiH 2010 The role of complement Factor H in age-related macular degeneration: a review. Surv Ophthalmol 55 227 246
3. RichardsJBYuanXGellerFWaterworthDBatailleV 2008 Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40 1282 1284
4. HillmerAMBrockschmidtFFHannekenSEigelshovenSSteffensM 2008 Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 40 1279 1281
5. HamiltonJB 1951 Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53 708 728
6. LoJCFeigenbaumSLYangJPressmanARSelbyJV 2006 Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 91 1357 1363
7. GilesGGSeveriGSinclairREnglishDRMcCredieMR 2002 Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 11 549 553
8. JemalATiwariRCMurrayTGhafoorASamuelsA 2004 Cancer statistics, 2004. CA Cancer J Clin 54 8 29
9. HeinleinCAChangC 2004 Androgen receptor in prostate cancer. Endocr Rev 25 276 308
10. JiaLLandanGPomerantzMJaschekRHermanP 2009 Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 5 e1000597 doi:10.1371/journal.pgen.1000597
11. LuYZhangZYuHZhengSLIsaacsWB 2011 Functional annotation of risk loci identified through genome-wide association studies for prostate cancer. Prostate 71 955 963
12. EllisJASinclairRHarrapSB 2002 Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 4 1 11
13. SuzukiHUedaTIchikawaTItoH 2003 Androgen receptor involvement in the progression of prostate cancer. Endocr Relat Cancer 10 209 216
14. HayesVMSeveriGEggletonSAPadillaEJSoutheyMC 2005 The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 14 993 996
15. HayesVMSeveriGPadillaEJMorrisHATilleyWD 2007 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer 120 776 780
16. CremersRGAbenKKVermeulenSHden HeijerMvan OortIM 2010 Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer. Eur J Cancer 46 3294 3299
17. WrightJLPageSTLinDWStanfordJL 2010 Male pattern baldness and prostate cancer risk in a population-based case-control study. Cancer Epidemiol 34 131 135
18. YassaMSaliouMDe RyckeYHemeryCHenniM 2011 Male pattern baldness and the risk of prostate cancer. Ann Oncol
19. YuXGuptaAWangYSuzukiKMirosevichJ 2005 Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Ann N Y Acad Sci 1061 77 93
20. MirosevichJGaoNGuptaAShappellSBJoveR 2006 Expression and role of Foxa proteins in prostate cancer. Prostate 66 1013 1028
21. QiJNakayamaKCardiffRDBorowskyADKaulK 2010 Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18 23 38
22. YuXWangYDegraffDJWillsMLMatusikRJ 2011 Wnt/beta-Catenin activation promotes prostate tumor progression in a mouse model. Oncogene 30 1868 1879
23. MartinMKettmannRDequiedtF 2007 Class IIa histone deacetylases: regulating the regulators. Oncogene 26 5450 5467
24. JeongBCHongCYChattopadhyaySParkJHGongEY 2004 Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase. Mol Endocrinol 18 13 25
25. SuhJHShongMChoiHSLeeK 2008 CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction. Mol Endocrinol 22 33 46
26. HalkidouKCookSLeungHYNealDERobsonCN 2004 Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate. European urology 45 382 389; author reply 389
27. PetrieKGuidezFHowellLHealyLWaxmanS 2003 The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem 278 16059 16072
28. AmannJMNipJStromDKLutterbachBHaradaH 2001 ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol 21 6470 6483
29. HaimanCAChenGKBlotWJStromSSBerndtSI 2011 Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet 43 570 573
30. SchumannGCoinLJLourdusamyACharoenPBergerKH 2011 Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A 108 7119 7124
31. HeroldCSteffensMBrockschmidtFFBaurMPBeckerT 2009 INTERSNP: genome-wide interaction analysis guided by a priori information. Bioinformatics 25 3275 3281
32. MassieCEAdryanBBarbosa-MoraisNLLynchAGTranMG 2007 New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep 8 871 878
33. HuSYaoGGuanXNiZMaW 2010 Research resource: Genome-wide mapping of in vivo androgen receptor binding sites in mouse epididymis. Mol Endocrinol 24 2392 2405
34. EdwardsTLScottWKAlmonteCBurtAPowellEH 2010 Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74 97 109
35. Simon-SanchezJSchulteCBrasJMSharmaMGibbsJR 2009 Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41 1308 1312
36. HamzaTHZabetianCPTenesaALaederachAMontimurroJ 2010 Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 42 781 785
37. SpencerCCPlagnolVStrangeAGardnerMPaisan-RuizC 2011 Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 20 345 353
38. NallsMAPlagnolVHernandezDGSharmaMSheerinUM 2011 Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377 641 649
39. Do CBTJDorfmanEKieferAKDrabantEM 2011 Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 7 e1002141 doi:10.1371/journal.pgen.1002141
40. de LauLMBretelerMM 2006 Epidemiology of Parkinson's disease. Lancet Neurol 5 525 535
41. MiwaHKondoT 2003 Hair loss induced by dopamine agonist: case report and review of the literature. Parkinsonism Relat Disord 10 51 52
42. CunninghamRLGiuffridaARobertsJL 2009 Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta. Endocrinology 150 5539 5548
43. Van Den EedenSKTannerCMBernsteinALFrossRDLeimpeterA 2003 Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157 1015 1022
44. StefanssonHHelgasonAThorleifssonGSteinthorsdottirVMassonG 2005 A common inversion under selection in Europeans. Nat Genet 37 129 137
45. VoightBFKudaravalliSWenXPritchardJK 2006 A map of recent positive selection in the human genome. PLoS Biol 4 e72 doi:10.1371/journal.pbio.0040072
46. NestlerJE 2008 Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med 358 47 54
47. CareyAHWaterworthDPatelKWhiteDLittleJ 1994 Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3 1873 1876
48. GovindAObhraiMSClaytonRN 1999 Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84 38 43
49. PastorPEzquerraMPerezJCChakravertySNortonJ 2004 Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Ann Neurol 56 249 258
50. RademakersRCrutsMvan BroeckhovenC 2004 The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 24 277 295
51. SchragABen-ShlomoYQuinnNP 1999 Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354 1771 1775
52. TogasakiDMTannerCM 2000 Epidemiologic aspects. Adv Neurol 82 53 59
53. RatnavalliEBrayneCDawsonKHodgesJR 2002 The prevalence of frontotemporal dementia. Neurology 58 1615 1621
54. ParkJHWacholderSGailMHPetersUJacobsKB 2010 Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 42 570 575
55. LiYWillerCJDingJScheetPAbecasisGR 2010 MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34 816 834
56. MarchiniJHowieBMyersSMcVeanGDonnellyP 2007 A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 906 913
57. MagiRMorrisAP 2010 GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 11 288
58. BaldingDJ 2006 A tutorial on statistical methods for population association studies. Nat Rev Genet 7 781 791
59. FrazerKABallingerDGCoxDRHindsDAStuveLL 2007 A second generation human haplotype map of over 3.1 million SNPs. Nature 449 851 861
60. 2011 A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 43 339 344
61. CuzickJ 1985 A Wilcoxon-type test for trend. Stat Med 4 87 90
62. YuWYesupriyaAWulfAHindorffLADowlingN 2011 GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies. Eur J Hum Genet 19 1095 1099
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 5
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
- Genome-Wide Association of Pericardial Fat Identifies a Unique Locus for Ectopic Fat
- Slowing Replication in Preparation for Reduction
- Deletion of PTH Rescues Skeletal Abnormalities and High Osteopontin Levels in Mice